{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:21:48Z","timestamp":1790248908412,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,11]]},"DOI":"10.7759\/cureus.58026","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T10:26:40Z","timestamp":1712831200000},"source":"Crossref","is-referenced-by-count":2,"title":["A Cross-Sectional Evaluation of Cardiovascular Risk Assessment in Type 2 Diabetes Mellitus Patients Using the Framingham Risk Score"],"prefix":"10.7759","author":[{"given":"Mitali B","family":"Rathod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashum","family":"Moukthika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allwyn John","family":"Karikunnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kottala","family":"Harika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathibha","family":"Talla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhurika","family":"Jalakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun H","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al.. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022, 183:109119. 10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2019.12.005","article-title":"Cardiovascular disease in India: a 360 degree overview","volume":"76","author":"Sreeniwas Kumar A","year":"2020","unstructured":"Sreeniwas Kumar A, Sinha N. Cardiovascular disease in India: a 360 degree overview. Med J Armed Forces India. 2020, 76:1-3. 10.1016\/j.mjafi.2019.12.005","journal-title":"Med J Armed Forces India"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth GA","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al.. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020, 76:2982-3021. 10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson TR","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018, 17:83. 10.1186\/s12933-018-0728-6","journal-title":"Cardiovasc Diabetol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar N","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, et al.. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010, 375:2215-22. 10.1016\/S0140-6736(10)60484-9","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","year":"2019","unstructured":"World Health Organization cardiovascular disease risk charts. revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019, 7:e1332-45. 10.1016\/S2214-109X(19)30318-3","journal-title":"Lancet Glob Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27208-5","article-title":"Cardiovascular risk factors in diabetic patients with and without metabolic syndrome: a study based on the Rafsanjan cohort study","volume":"13","author":"Bazmandegan G","year":"2023","unstructured":"Bazmandegan G, Abbasifard M, Nadimi AE, Alinejad H, Kamiab Z. Cardiovascular risk factors in diabetic patients with and without metabolic syndrome: a study based on the Rafsanjan cohort study. Sci Rep. 2023, 13:559. 10.1038\/s41598-022-27208-5","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","year":"2020","unstructured":"2. Classification and diagnosis of diabetes. standards of medical care in diabetes-2020. Diabetes Care. 2020, 43:S14-31. 10.2337\/dc20-S002","journal-title":"Diabetes Care"},{"key":"ref9","article-title":"Practical human biology","author":"Weiner JS","year":"1981","unstructured":"Weiner JS, Lourie JA. Practical human biology. Academic Press, London, UK; 1981."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2013.01.001","article-title":"Cardiovascular disease risk assessment: insights from Framingham","volume":"8","author":"D'Agostino RB Sr","year":"2013","unstructured":"D'Agostino RB Sr, Pencina MJ, Massaro JM, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart. 2013, 8:11-23. 10.1016\/j.gheart.2013.01.001","journal-title":"Glob Heart"},{"key":"ref11","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106.3143-421.","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-021-00761-y","article-title":"Cardiovascular diseases risk prediction in patients with diabetes: posthoc analysis from a matched case-control study in Bangladesh","volume":"20","author":"Islam SM","year":"2021","unstructured":"Islam SM, Ahmed S, Uddin R, et al.. Cardiovascular diseases risk prediction in patients with diabetes: posthoc analysis from a matched case-control study in Bangladesh. J Diabetes Metab Disord. 2021, 20:417-25. 10.1007\/s40200-021-00761-y","journal-title":"J Diabetes Metab Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S404054","article-title":"Cardiovascular risk among patients with controlled and uncontrolled type 2 diabetes: a sub-cohort analysis from the Heart Health Promotion (HHP) study","volume":"16","author":"Fayed A","year":"2023","unstructured":"Fayed A, Alzeidan R, Elkouny R, Tawfik M, Naguib R. Cardiovascular risk among patients with controlled and uncontrolled type 2 diabetes: a sub-cohort analysis from the Heart Health Promotion (HHP) study. Int J Gen Med. 2023, 16:1171-80. 10.2147\/IJGM.S404054","journal-title":"Int J Gen Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263619","article-title":"Cardiovascular risk in newly diagnosed type 2 diabetes patients in India","volume":"17","author":"Unnikrishnan AG","year":"2022","unstructured":"Unnikrishnan AG, Sahay RK, Phadke U, et al.. Cardiovascular risk in newly diagnosed type 2 diabetes patients in India. PLoS One. 2022, 17:e0263619. 10.1371\/journal.pone.0263619","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2019.90416","article-title":"A prospective observational study on cardiovascular risk assessment in type-2 diabetes mellitus patients","volume":"9","author":"Maharana L","year":"2019","unstructured":"Maharana L, Reddy SK, Pattnaik S, et al.. A prospective observational study on cardiovascular risk assessment in type-2 diabetes mellitus patients. J Appl Pharm Sci. 2019, 9:126-32. 10.7324\/JAPS.2019.90416","journal-title":"J Appl Pharm Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46687","article-title":"Cardiovascular risk assessment among people with type 2 diabetes mellitus in urban slums of Central Karnataka, India","volume":"15","author":"Davalagi S","year":"2023","unstructured":"Davalagi S, Amuje R, H S. Cardiovascular risk assessment among people with type 2 diabetes mellitus in urban slums of Central Karnataka, India. Cureus. 2023, 15:e46687. 10.7759\/cureus.46687","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga A","year":"2017","unstructured":"Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017, 8:33. 10.1186\/s13293-017-0152-8","journal-title":"Biol Sex Differ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.162446","article-title":"Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure","volume":"57","author":"Chen G","year":"2011","unstructured":"Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011, 57:891-7. 10.1161\/HYPERTENSIONAHA.110.162446","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33743-6","article-title":"Changes in total cholesterol level and cardiovascular disease risk among type 2 diabetes patients","volume":"13","author":"Khil J","year":"2023","unstructured":"Khil J, Kim SM, Chang J, et al.. Changes in total cholesterol level and cardiovascular disease risk among type 2 diabetes patients. Sci Rep. 2023, 13:8342. 10.1038\/s41598-023-33743-6","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103368","article-title":"Profile of cardiovascular disease risk in type 2 diabetes mellitus patients receiving statin therapy: a cross-sectional study","volume":"75","author":"Ikhsan YK","year":"2022","unstructured":"Ikhsan YK, Soelistijo SA, Putranto JN. Profile of cardiovascular disease risk in type 2 diabetes mellitus patients receiving statin therapy: a cross-sectional study. Ann Med Surg (Lond). 2022, 75:103368. 10.1016\/j.amsu.2022.103368","journal-title":"Ann Med Surg (Lond)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2174\/092986732134141015161539","article-title":"Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches","volume":"21","author":"Siasos G","year":"2014","unstructured":"Siasos G, Tsigkou V, Kokkou E, et al.. Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Curr Med Chem. 2014, 21:3936-48. 10.2174\/092986732134141015161539","journal-title":"Curr Med Chem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082896","article-title":"Diabetic cardiomyopathy and ischemic heart disease: prevention and therapy by exercise and conditioning","volume":"21","author":"Crisafulli A","year":"2020","unstructured":"Crisafulli A, Pagliaro P, Roberto S, et al.. Diabetic cardiomyopathy and ischemic heart disease: prevention and therapy by exercise and conditioning. Int J Mol Sci. 2020, 21:2896. 10.3390\/ijms21082896","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2439","article-title":"Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study","volume":"39","author":"Wong ND","year":"2016","unstructured":"Wong ND, Zhao Y, Patel R, et al.. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study. Diabetes Care. 2016, 39:668-76. 10.2337\/dc15-2439","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244390-a-cross-sectional-evaluation-of-cardiovascular-risk-assessment-in-type-2-diabetes-mellitus-patients-using-the-framingham-risk-score","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T10:26:43Z","timestamp":1712831203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244390-a-cross-sectional-evaluation-of-cardiovascular-risk-assessment-in-type-2-diabetes-mellitus-patients-using-the-framingham-risk-score"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.58026","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,11]]}}}